However, GLP-1RA are contraindicated for use in individuals with predisposition to MEN2 and medullary thyroid carcinoma (112)
Still, the authors said they were encouraged that patients on the drug did not get worse, and the findings add to a growing body of research that suggests this class of medications holds potential as a new way of addressing Parkinsons, a slow-moving, debilitating disorder that currently lacks any treatments that can halt disease progression
Over-the-counter options Simethicone (Gas-X, Mylanta Gas) works by breaking down gas bubbles in the digestive tract, making them easier to pass
For patients wanting a gentle, well-established GHRH peptide, sermorelin is often the starting point
Sold for Research Use Only / Not FDA Regulated
This is why patients with neurological involvement are often maintained on a more frequent schedule (every 2 months rather than every 3 months)